Clinical Trial Update: Total Neoadjuvant Therapy in Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating total neoadjuvant therapy for rectal cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Rectal Cancer | Phase 2 | Status: RECRUITING